Early research (Phase 1)Ended earlyNCT01258868
What this trial is testing
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Who this might be right for
MesoltheliomaEsophageal CancerLung Cancer+2 more
National Cancer Institute (NCI) 44